128 related articles for article (PubMed ID: 22825237)
1. Clobazam, ezogabine, and tafluprost.
Hussar DA; Hallinan SE
J Am Pharm Assoc (2003); 2012; 52(4):546-50. PubMed ID: 22825237
[No Abstract] [Full Text] [Related]
2. Clobazam approved for seizure disorder.
Traynor K
Am J Health Syst Pharm; 2011 Dec; 68(23):2204. PubMed ID: 22095800
[No Abstract] [Full Text] [Related]
3. The use of clobazam as an adjunctive treatment for Lennox-Gastaut syndrome.
Owen RT
Drugs Today (Barc); 2012 Nov; 48(11):697-703. PubMed ID: 23170305
[TBL] [Abstract][Full Text] [Related]
4. Clobazam (Onfi) for Lennox-Gastaut syndrome.
Med Lett Drugs Ther; 2012 Mar; 54(1385):18-9. PubMed ID: 22382580
[No Abstract] [Full Text] [Related]
5. Clobazam for patients with Lennox-Gastaut syndrome and epilepsy.
Seif-Eddeine H; Ng YT
Expert Rev Neurother; 2012 Apr; 12(4):385-93. PubMed ID: 22449211
[TBL] [Abstract][Full Text] [Related]
6. Clobazam : in patients with Lennox-Gastaut syndrome.
Yang LP; Scott LJ
CNS Drugs; 2012 Nov; 26(11):983-91. PubMed ID: 23034582
[TBL] [Abstract][Full Text] [Related]
7. New antiepileptic drugs: focus on ezogabine, clobazam, and perampanel.
Rudzinski LA; Vélez-Ruiz NJ; Gedzelman ER; Mauricio EA; Shih JJ; Karakis I
J Investig Med; 2016 Aug; 64(6):1087-101. PubMed ID: 27252470
[TBL] [Abstract][Full Text] [Related]
8. Long-term safety and efficacy of clobazam for Lennox-Gastaut syndrome: interim results of an open-label extension study.
Ng YT; Conry J; Paolicchi J; Kernitsky L; Mitchell W; Drummond R; Isojarvi J; Lee D; Owen R;
Epilepsy Behav; 2012 Dec; 25(4):687-94. PubMed ID: 23141144
[TBL] [Abstract][Full Text] [Related]
9. Stable dosages of clobazam for Lennox-Gastaut syndrome are associated with sustained drop-seizure and total-seizure improvements over 3 years.
Conry JA; Ng YT; Kernitsky L; Mitchell WG; Veidemanis R; Drummond R; Isojarvi J; Lee D; Paolicchi JM;
Epilepsia; 2014 Apr; 55(4):558-67. PubMed ID: 24580023
[TBL] [Abstract][Full Text] [Related]
10. Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome.
Ng YT; Conry JA; Drummond R; Stolle J; Weinberg MA;
Neurology; 2011 Oct; 77(15):1473-81. PubMed ID: 21956725
[TBL] [Abstract][Full Text] [Related]
11. Indirect comparison of clobazam and other therapies for Lennox-Gastaut syndrome.
Cramer JA; Sapin C; François C
Acta Neurol Scand; 2013 Aug; 128(2):91-9. PubMed ID: 23410109
[TBL] [Abstract][Full Text] [Related]
12. Levetiracetam efficacy in patients with Lennox-Gastaut syndrome. Presentation of a case.
Díaz Negrillo A; Martín Del Valle F; González Salaices M; Prieto Jurczynska C; Carneado Ruiz J
Neurologia; 2011 Jun; 26(5):285-90. PubMed ID: 21353345
[TBL] [Abstract][Full Text] [Related]
13. Update on the management of Lennox-Gastaut syndrome.
VanStraten AF; Ng YT
Pediatr Neurol; 2012 Sep; 47(3):153-61. PubMed ID: 22883278
[TBL] [Abstract][Full Text] [Related]
14. [Levetiracetam-induced aggravation to non-convulsive status epilepticus in a boy with Lennox-Gastaut syndrome].
Isoda K; Tomoyasu C; Fujii N; Nishimura A
No To Hattatsu; 2012 Sep; 44(5):401-2. PubMed ID: 23012871
[No Abstract] [Full Text] [Related]
15. Cost-effectiveness analysis of antiepileptic drugs in the treatment of Lennox-Gastaut syndrome.
Clements KM; Skornicki M; O'Sullivan AK
Epilepsy Behav; 2013 Oct; 29(1):184-9. PubMed ID: 23973644
[TBL] [Abstract][Full Text] [Related]
16. Valproate treatment after liver transplant in a patient with Lennox-Gastaut syndrome.
Velizarova R; Gelisse P; Pageaux GP; Genton P; Crespel A
Seizure; 2011 Jul; 20(6):500-1. PubMed ID: 21376637
[TBL] [Abstract][Full Text] [Related]
17. Clobazam therapeutic drug monitoring: a comprehensive review of the literature with proposals to improve future studies.
de Leon J; Spina E; Diaz FJ
Ther Drug Monit; 2013 Feb; 35(1):30-47. PubMed ID: 23318278
[TBL] [Abstract][Full Text] [Related]
18. Withdrawal-related adverse events from clinical trials of clobazam in Lennox-Gastaut syndrome.
Tolbert D; Harris SI; Bekersky I; Lee D; Isojarvi J
Epilepsy Behav; 2014 Aug; 37():11-5. PubMed ID: 24949576
[TBL] [Abstract][Full Text] [Related]
19. Clobazam and Aggression-Related Adverse Events in Pediatric Patients With Lennox-Gastaut Syndrome.
Paolicchi JM; Ross G; Lee D; Drummond R; Isojarvi J
Pediatr Neurol; 2015 Oct; 53(4):338-42. PubMed ID: 26245776
[TBL] [Abstract][Full Text] [Related]
20. Long-term use of clobazam in Lennox-Gastaut syndrome: experience in a single tertiary epilepsy center.
Lee EH; Yum MS; Choi HW; Ko TS
Clin Neuropharmacol; 2013; 36(1):4-7. PubMed ID: 23334068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
